BURLINGTON, Mass., Aug. 1, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment of autoimmune diseases and cancer, announced today that Dr. Harlan F. Weisman, Coronado's Chairman and CEO, will present at the following upcoming investor conferences:
- Wedbush 2013 Life Sciences Management Access Conference on Tuesday, August 13, 2013 at 10:55 AM ET. The conference will be held at Le Parker Meridien in New York City. A webcast of the presentation will be available at www.coronadobiosciences.com on the Events & Webcasts page.
- Canaccord Genuity 33rd Annual Growth Conference on Wednesday, August 14, 2013 at 9:30 AM ET. The conference will be held at the Intercontinental Boston in Boston, MA.
CONTACT: Lucy Lu, MD, Executive Vice President & Chief Financial Officer Coronado Biosciences, Inc. 781-652-4525; email@example.com Marcy Nanus, Vice President The Trout Group, LLC. 646-378-2927; firstname.lastname@example.org Susan Forman Dian Griesel Inc. 212-825-3210; email@example.com